Jm. Herbert et al., IL-4 AND IL-13 EXHIBIT COMPARABLE ABILITIES TO REDUCE PYROGEN-INDUCEDEXPRESSION OF PROCOAGULANT ACTIVITY IN ENDOTHELIAL-CELLS AND MONOCYTES, FEBS letters, 328(3), 1993, pp. 268-270
Endotoxin (LPS), interleukin-1beta (IL-1) and tumor necrosis factor-al
pha (TNF) increased the expression of tissue factor, a membrane-anchor
ed glycoprotein that initiates blood coagulation on the surface of cul
tured bovine aortic endothelial cells (ABAE) and human monocytes. Thes
e compounds simultaneously reduced the amount of thrombomodulin on the
endothelial cell surface, further contributing to the procoagulant ac
tivity of the endothelium or monocytes. On endothelial cells and monoc
ytes, interleukin-4 (IL-4) and interleukin-13 (IL-13), a newly describ
ed lymphokine, both strongly inhibited LPS-induced tissue factor expre
ssion, a similar activity also being obtained with regard to the pyrog
enic effects of IL-1 or TNF. When measured in parallel, IL-4 and IL-13
counteracted thrombomodulin down-regulation induced by LPS, IL-1 or T
NF in endothelial cells. These results therefore show that both IL4 an
d IL-13 protect the endothelial and the monocyte surface against infla
mmatory mediator- induced procoagulant changes.